203 related articles for article (PubMed ID: 36996726)
1. Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics.
Polk JB; Campbell J; Drilon AE; Keating P; Cambrosio A
Soc Sci Med; 2023 May; 324():115789. PubMed ID: 36996726
[TBL] [Abstract][Full Text] [Related]
2. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
[TBL] [Abstract][Full Text] [Related]
4. Decision-making as discovery: Vetting clinical research in a leading precision oncology service.
Cambrosio A; Campbell J; Drilon AE; Keating P; Polk JB
Sociol Health Illn; 2024 Mar; 46(3):495-513. PubMed ID: 37796533
[TBL] [Abstract][Full Text] [Related]
5. Bringing Precision Medicine to Community Oncologists.
Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
[TBL] [Abstract][Full Text] [Related]
6. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
7. OncoTree: A Cancer Classification System for Precision Oncology.
Kundra R; Zhang H; Sheridan R; Sirintrapun SJ; Wang A; Ochoa A; Wilson M; Gross B; Sun Y; Madupuri R; Satravada BA; Reales D; Vakiani E; Al-Ahmadie HA; Dogan A; Arcila M; Zehir A; Maron S; Berger MF; Viaplana C; Janeway K; Ducar M; Sholl L; Dogan S; Bedard P; Surrey LF; Sanchez IH; Syed A; Rema AB; Chakravarty D; Suehnholz S; Nissan M; Iyer GV; Murali R; Bouvier N; Soslow RA; Hyman D; Younes A; Intlekofer A; Harding JJ; Carvajal RD; Sabbatini PJ; Abou-Alfa GK; Morris L; Janjigian YY; Gallagher MM; Soumerai TA; Mellinghoff IK; Hakimi AA; Fury M; Huse JT; Bagrodia A; Hameed M; Thomas S; Gardos S; Cerami E; Mazor T; Kumari P; Raman P; Shivdasani P; MacFarland S; Newman S; Waanders A; Gao J; Solit D; Schultz N
JCO Clin Cancer Inform; 2021 Feb; 5():221-230. PubMed ID: 33625877
[TBL] [Abstract][Full Text] [Related]
8. Building a personalized medicine infrastructure at a major cancer center.
Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
[TBL] [Abstract][Full Text] [Related]
9. First Person Profile: Clifford Hudis, MD: The chief executive officer of the American Society of Clinical Oncology previously had an esteemed career as a physician-scientist and executive at the Memorial Sloan Kettering Cancer Center's Breast Medicine Service: The chief executive officer of the American Society of Clinical Oncology previously had an esteemed career as a physician-scientist and executive at the Memorial Sloan Kettering Cancer Center's Breast Medicine Service.
O'Rourke K
Cancer; 2022 Mar; 128(5):936-937. PubMed ID: 35147985
[No Abstract] [Full Text] [Related]
10. Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial.
Mainoli B; Assis J; Dinis J; Henrique R; Oliveira J
Acta Oncol; 2024 Jun; 63():482-486. PubMed ID: 38910310
[TBL] [Abstract][Full Text] [Related]
11. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
12. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
13. Recent Advancements and Innovations in Pediatric Precision Oncology.
Mangum R; Lin FY; Parsons DW
J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
[TBL] [Abstract][Full Text] [Related]
14. Progress in precision therapy in pediatric oncology.
O'Donohue T; Farouk Sait S; Glade Bender J
Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
16. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
17. Pediatric oncology enters an era of precision medicine.
Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW
Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740
[TBL] [Abstract][Full Text] [Related]
18. Innovative trial design in precision oncology.
Tsimberidou AM; Müller P; Ji Y
Semin Cancer Biol; 2022 Sep; 84():284-292. PubMed ID: 33022355
[TBL] [Abstract][Full Text] [Related]
19. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
20. Delivering precision oncology to patients with cancer.
Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]